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â-Lactamases are a major cause of bacterial resistance to
â-lactam antibiotics such as penicillins, cephalosporins, carbapen-
ems, and monobactams.1,2 An efficient strategy to overcome the
resistance of â-lactamase-containing pathogens to â-lactam antibiot-
ics is co-administration of the enzyme-susceptible â-lactam with a
â-lactamase inhibitor.3 BRL 42715, C6-(N1-methyl-1,2,3-triazolyl-
methylene)penem, 1 (Scheme 1), is an active-site-directed inacti-
vator of a broad range of bacterial â-lactamases, including the class
C enzymes.4,5 This compound is very active as reflected in the low
concentrations of 1 needed to potentiate the antibacterial activity
of â-lactamase-susceptible â-lactams.6-11
The interactions of â-lactamases of classes A, B, C and D with
1 were investigated kinetically.12 The mechanism of action of 1
toward class C â-lactamases is here investigated and the crystal
structure of Enterobacter cloacae 908R â-lactamase in complex
with 1 is reported (Table 1).
A stable covalent adduct, a cyclic â-aminoacrylate-enzyme
complex, resulting from acylation of the active site serine by the
penem followed by intramolecular rearrangement leads to the
corresponding dihydrothiazepine (Figure 1). The â-lactamyl car-
bonyl of the covalent adduct is situated in the oxyanion hole
between helix H2 and â-strand B3 where it is H-bonded to Ser318.
Orientation of the ligand into the active site is the result of a series
of interactions: (i) the methyl triazolyl cycle stacks with Tyr221
and the N3′ atom is involved in H bonding with Asn152 (2.98 Å);
(ii) the N4 atom is hydrogen-bonded (2.59 Å) to a water molecule
stabilized by two other water molecules; (iii) the carboxylate group,
which interacts with another water molecule (3.1 Å) and lies near
Asn346 and Ser289, and the triazolyl group are situated on the
opposite side of the dihydrothiazepine ring; (iv) the sulfur atom of
the dihydrothiazepine cycle lies near Leu119, Asn152, Lys67, and
Tyr150.
This structure confirms a mechanism that implies opening of
the five-membered thiazole ring system at the C5-S bond upon
alcoholysis and rearrangement via a Michael addition to form a
seven-membered dihydrothiazepine ring system (Scheme 2).
This structure is in good agreement with spectral properties of
the product that are identical to those of the dihydrothiazepine
obtained after sodium hydroxide hydrolysis13 and with mass
spectrometry results.12
The binding mode and geometry of the covalent adduct of 1d in
class C 908R â-lactamase are quite different from that of a penem
analogue, 2 (Scheme 1), in complex with class C extended-spectrum
GC1 â-lactamase14 but consistent with differences observed for a
transition-state analogue of cefotaxime in the parental and extended-
spectrum enzymes.15 In particular, the absolute configuration of
the cyclic â-aminoacrylate-enzyme complex 1d is S while the other
enantiomer of 2 forms upon complexation with GC1 â-lactamase.
The absolute configuration at the stereogenic carbon C7 observed
in the structure 1d is consistent with indirect evidences of the
literature.16
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Scheme 1. Chemical Structure of Methylene Penem Inactivators
Table 1. Data Collection and Refinement Statistics
space group P21212
cell index (Å) a ) 44.158 completeness (%)a 98.5
b ) 82.042 (89.6)a
c ) 95.709 Rsyma,b 7.1 (21.6)a
I/óa 7.8 (2.4)a
wavelength (Å) 0.966 Rwork/Rfreec 22.7/29.2
resolution (Å) 2.07 rmsd from ideal geometry
unique reflections 20153 bonds (Å) 0.007
observed reflections 15035 angles (deg) 0.021
a Values listed in parentheses are for the resolution shell (2.11-2.07
Å). b Rsym ) ∑jI - 〈I〉j/∑. c Rfactor ) ∑jjFoj - jFcjj/∑jFoj. Rfree was
calculated with 10% of the reflections set aside randomly throughout the
refinement.
Figure 1. 908R â-lactamase binding site (stereoview) complexed with
intermediate 1d (PDB File 1Y54). Red crosses stand for water molecules.
Scheme 2. Opening of the Five-Membered Thiazole Ring System
of 1 (a) Leading to a Cyclic â-Aminoacrylate-Enzyme Complex (d)
Covalently Bound to the Enzyme via Ser64
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The overall structure of the GC1 enzyme is equivalent to that of
the 908R enzyme. In the later structure, the so-called ¿ loop (189-
226) is well defined. The extended specificity of the GC1 enzyme
appears to be entirely due to only additional three residues (213-
215) after position 210 in this ¿ loop.17,18 These additional amino
acids lead to a more flexible binding site and allow an alternative
fold (“open folding”) in which Tyr224 (equivalent to Tyr221 in
908R) is displaced by 6 Å relative to its position in the free
enzyme. As a result, the main difference between the two enzymes
complexes is the position of this tyrosine residue. This has
consequences for the binding mode of the ligand. Indeed, in 908R
the triazolyl cycle of 1 is able to stack with Tyr221, unlike the
heterocyclic double ring of 2 in GC1. Moreover, the carboxylate
moiety of 1 does not interact with Gln120 and Asn152 while it
does so for 2 in CG1. This explains why the absolute configuration
is reversed.
Docking and energy minimization studies19 were performed to
further understand and quantify differences in conformation and
stereochemistry between the complexes observed with the 908R
and GC1 class C â-lactamases. Those preliminary calculations open
interesting perspectives.
A structure corresponding to an intermediate covalently bound
to Ser64 (Scheme 2) of both penems 1 and 2 was obtained by
docking simulation (Figure 2; a stereoview of these complexes is
available in the Supporting Information). In the case of 1, the
triazolyl moiety is close to Tyr221, and the thiolate group lies along
the B3 â-strand. The S isomer of the compound is therefore strongly
favored.
Indeed, the thiolate group is only able to react with one side of
the double bond. In contrast, the heterocyclic ring of 2 binds along
the B3 â-strand, as in the crystal complex with intermediate d. The
thiolate moiety is near Leu119 and Gln120 and is positioned in
such a way that only intermediate 2d with R configuration can be
produced. The binding energy of the two complexes is -63.4 and
-51.8 kcal/mol for 1 and 2, respectively. As a result, flexibility of
Tyr221 resulting from the conformation of the ¿ loop would be,
in large part, responsible for the position and stereochemistry of
the ligand in the binding site. Interaction with this residue was also
considered as essential for the binding of ceftazidime and its
transition-state analogue to Citrobacter freundii GN346 â-lacta-
mase.15 Furthermore, a recent crystal structure of GC1 in complex
with another penem inhibitor (3), shows both R and S configurations
with 30% and 70% occupancies, respectively.20 In this later
complex, the ¿ loop is in the same position (“close folding”) as in
908R, positioning Tyr224 (Tyr221) near the active site.
To test our hypothesis, the reaction product in R and S
configurations for 1 and 2 was docked in the corresponding enzyme
and the binding energy of the complex was evaluated. In the case
of 1 with the R configuration, the carboxylate group points toward
the water surface and the triazolyl ring lies near Tyr150, Thr316,
and Asn346 (data not shown). Such a complex is less stable than
that of 1 with the S configuration (¢¢E ) 11.0 kcal/mol) (Figure
2). It is noteworthy that the docked complex of the S isomer is
close to the observed crystal one but remains slightly different
because the constrained cocrystal conformation of 1 cannot be
modeled by the docking program. In the case of 2, the heterocyclic
group of the S isomer is buried near Gly63, Ser64, Asn152, Gln222,
Ala223, Gly225, and Ser321. The carboxylate group interacts with
Gln120 and lies close to the solvent surface. The modeled R
complex, similar to the crystal one, is more stable than the S
complex (¢¢E ) 7.1 kcal/mol).
These preliminary analyses confirm the stereoselective mecha-
nism of action of 1 and of methylidene penem inactivators in general
toward class C â-lactamases as illustrated in Figure 2.
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Figure 2. Energy diagrams for (a) the reaction of 1 with a class C
â-lactamase in the “close folding”; (b) the reaction of 2 with a class C
â-lactamase in the “open folding”.
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